Sequence Variants of Toll-Like Receptor 4 Are Associated with Prostate Cancer Risk: Results from the CAncer Prostate in Sweden Study

Cancer Research

Volumn 64, Issue 8, 2004, Pages 2918-2922

  Zheng, S Lilly ^a   Augustsson Bälter, Katarina ^b   Chang, Baoli ^a   Hedelin, Maria ^b   Li, Liwu ^a   Adami, Hans Olov ^b   Bensen, Jeanette ^a   Li, Ge ^a   Johnasson, Jan Erik ^d,e   Turner, Aubrey R ^a   Adams, Tamara S ^a   Meyers, Deborah A ^a   Isaacs, William B ^f   Xu, Jianfeng ^a   Grönberg, Henrik ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^f DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 4;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; TLR4 GENE;

3' UNTRANSLATED REGIONS; ADENOCARCINOMA; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 8444235603     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3280     Document Type: Article

References (23)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature (Lond) 2002;420:860-7.
2. Gardner WA Jr, Bennett BD. The prostate-overview: recent insights and speculations Monogr Pathol 1992;34:129-48.
3. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999;155:1985-92.
4. Shah R, Mucci NR, Amin A, Macoska JA, Rubin MA. Postatrophic hyperplasia of the prostate gland. Neoplastic precursor of innocent bystander? Am J Pathol 2001;158:1767-73.
5. Carpten J, Nupponen N, Isaacs S, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002;30:181-4.
6. Xu J, Zheng SL, Komiya A, et al. Germline mutations and sequence variants of the macrophage scavenger receptor I gene are associated with Prostate cancer risk. Nat Genet 2002;32:321-5.
7. Li L. Regulation of innate immunity signaling and its connection with human diseases. Curr Drug Targets Inflamm Allergy. In press 2004.
8. Poltorak A, He X, Smirnova I, et al. Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene. Science (Wash DC) 1998;282:2085-8.
9. Vogel SN, Perera PY, Detore GR, et al. CD14 dependent and independent signaling pathways in murine macrophages from normal and CD14 "knockout" (CD14KO) mice stimulated with LPS or taxol. Prog Clin Biol Res 1998;397:137-46.
10. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000;164:558-61.
11. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-91.
12. Weir BS. Genetic data analysis II: methods for discrete population genetic data. Sunderland, MA: Sinauer Association, 1996.
13. Lillienfeld AM, Lillienfeld DE. Foundations of epidemiology, edition 2. New York: Oxford University Press, 1980.
14. Stephens M, Smith NJ, Donnelly PA. New statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
15. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-34.
16. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-82.
17. Schmitt C, Humeny A, Becker CM, Brune K, Pahl A. Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Clin Chem 2002;48:1661-7.
18. Lorenz E, Hallman M, Marttila R, Haataja R, Schwartz DA. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res 2002;52:373-6.
19. Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002;347:185-92.
20. Agnese DM, Calvano JE, Hahm SJ, et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002;186:1522-5.
21. Read RC, Pullin J, Gregory S, Bet al. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis 2001;184:640-2.
22. Erridge C, Stewart J, Poxton IR. Monocytes heterozygous for the Asp299Gly and Thr399lle mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J Exp Med 2003;197:1787-91.
23. Raby BA, Klimecki WT, Laprise C, et al. Polymorphisms; in toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am J Respir Crit Care Med 2002;166:1449-56.